Autopsy report · NCT02398825

Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib

“low enrollment rate”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 3 months before it started.
• Ran for about 6 years 6 months before it stopped.
• 14 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto

Sponsor type

University, hospital or other

Conditions

Chronic Myeloid Leukemia; Chronic Phase; Adults

Interventions

Ponatinib

Participants

14

Sites

37

Countries

Italy

Trials that died the same way

• Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1
  “Low rate of enrollment” (97% match in meaning)
• Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
  “Low enrollment rates.” (91% match in meaning)
• The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding
  “Low enroll rate” (90% match in meaning)
• Clinical Investigation of MONTAGE in Adults With Spinal Deformity Undergoing Pedicle Subtraction Osteotomy
  “Low enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.